846 related articles for article (PubMed ID: 28981597)
1. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma.
Vallée A; Lecarpentier Y; Vallée JN
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917605
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
Vallée A; Lecarpentier Y
Front Immunol; 2018; 9():745. PubMed ID: 29706964
[TBL] [Abstract][Full Text] [Related]
4. The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells.
Esposito G; De Filippis D; Carnuccio R; Izzo AA; Iuvone T
J Mol Med (Berl); 2006 Mar; 84(3):253-8. PubMed ID: 16389547
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPARγ involvement.
Scuderi C; Steardo L; Esposito G
Phytother Res; 2014 Jul; 28(7):1007-13. PubMed ID: 24288245
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol Modulates the Expression of Alzheimer's Disease-Related Genes in Mesenchymal Stem Cells.
Libro R; Diomede F; Scionti D; Piattelli A; Grassi G; Pollastro F; Bramanti P; Mazzon E; Trubiani O
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025562
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
[TBL] [Abstract][Full Text] [Related]
9. Rosmarinic acid attenuates β-amyloid-induced oxidative stress via Akt/GSK-3β/Fyn-mediated Nrf2 activation in PC12 cells.
Rong H; Liang Y; Niu Y
Free Radic Biol Med; 2018 May; 120():114-123. PubMed ID: 29555592
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of Wnt/β-catenin signaling pathway against Aβ -induced tau protein over-phosphorylation in PC12 cells.
Wang J; Jing Y; Song L; Xing Y
Biochem Biophys Res Commun; 2016 Mar; 471(4):628-32. PubMed ID: 26809093
[TBL] [Abstract][Full Text] [Related]
11. Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway.
Vallée A; Vallée JN; Guillevin R; Lecarpentier Y
Aging (Albany NY); 2020 Feb; 12(3):3095-3113. PubMed ID: 32035419
[TBL] [Abstract][Full Text] [Related]
12. Combination of PKCε Activation and PTP1B Inhibition Effectively Suppresses Aβ-Induced GSK-3β Activation and Tau Phosphorylation.
Kanno T; Tsuchiya A; Tanaka A; Nishizaki T
Mol Neurobiol; 2016 Sep; 53(7):4787-97. PubMed ID: 26328540
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease.
Pan K; Chen S; Wang Y; Yao W; Gao X
Neuropharmacology; 2021 Sep; 196():108671. PubMed ID: 34153312
[TBL] [Abstract][Full Text] [Related]
14. Sodium selenate activated Wnt/β-catenin signaling and repressed amyloid-β formation in a triple transgenic mouse model of Alzheimer's disease.
Jin N; Zhu H; Liang X; Huang W; Xie Q; Xiao P; Ni J; Liu Q
Exp Neurol; 2017 Nov; 297():36-49. PubMed ID: 28711506
[TBL] [Abstract][Full Text] [Related]
15. Reprogramming energetic metabolism in Alzheimer's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Life Sci; 2018 Jan; 193():141-152. PubMed ID: 29079469
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions.
Kang BW; Kim F; Cho JY; Kim S; Rhee J; Choung JJ
Alzheimers Res Ther; 2022 Jul; 14(1):92. PubMed ID: 35804462
[TBL] [Abstract][Full Text] [Related]
17. Potential role of cannabidiol in Parkinson's disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation.
Vallée A; Vallée JN; Lecarpentier Y
Aging (Albany NY); 2021 Apr; 13(7):10796-10813. PubMed ID: 33848261
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors.
Sonego AB; Prado DS; Vale GT; Sepulveda-Diaz JE; Cunha TM; Tirapelli CR; Del Bel EA; Raisman-Vozari R; Guimarães FS
Brain Behav Immun; 2018 Nov; 74():241-251. PubMed ID: 30217539
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg1 improves Alzheimer's disease by regulating oxidative stress, apoptosis, and neuroinflammation through Wnt/GSK-3β/β-catenin signaling pathway.
Yang Y; Wang L; Zhang C; Guo Y; Li J; Wu C; Jiao J; Zheng H
Chem Biol Drug Des; 2022 Jun; 99(6):884-896. PubMed ID: 35313087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
